mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.3 |